AIM ImmunoTech

Hemispherx Biopharma is a small American pharmaceutical company that produces the drug Ampligen. Corporate headquarters are in Philadelphia, PA and the manufacturing and research facility is in New Brunswick, NJ. In addition to Ampligen, Hemispherx produces Alferon N Injection® and Alferon® LDO (Low Dose Oral). To date, only Alferon N Injection® has FDA approval. Ampligen and Alferon® LDO are not FDA-approved and are considered experimental.

Online presence

 * Website
 * SEC filings - Hemispherx Biompharma

Learn more

 * Wikipedia - Hemispherx Biopharma


 * Wikipedia - Rintatolimod
 * http://simmaronresearch.com/2016/05/hemispherx-ampligen-approval-chronic-fatigue-syndrome-top-priority/
 * 2016, Hemispherx Biopharma (HEB) Comments on Recent Meeting with NIH for ME/CFS Research Advancement (see also NIH Post-Infectious ME/CFS Study)
 * 2016, Ampligen Co-Inventor / Head of Hemispherx Biopharma Fired: Implications for ME/CFS Drug Unclear (see also William Carter)